ÂÜÀòÂÒÂ×

Daniel G. Gibson. Dr. Gibson has served as the Chief Technology Officer since August 2018. From February 2011 to August 2018, Dr. Gibson served in various roles at Synthetic Genomics, Inc., the former parent company and a biotechnology company focused on synthetic biology, including Principal Scientist and Vice President of DNA Technology. Since 2004, Dr. Gibson has also served as a professor in the synthetic biology group at the J. Craig Venter Institute, a non-profit genomics research institute. Dr. Gibson earned a B.S. in Biological Sciences from the State University of New York at Buffalo and a PhD in Molecular Biology from the University of Southern California.